Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1152 of 1,261
  1. US 6752996

    Use of parapox PP30 protein to modify immune responses to administered antigens

    The Board of Regents of the University of Texas System Β· Granted Jun 22, 2004 Β· Expires Jun 17, 2024

    expired
  2. US 6753411

    Protection-of-telomere-1 (POT-1) proteins

    The Regents of the University of Colorado Β· Granted Jun 22, 2004 Β· Expires Jun 17, 2024

    expired
  3. US 6753317

    Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 22, 2004 Β· Expires Jun 17, 2024

    expired
  4. US 6752995

    Nucleic acid and polypeptide sequences useful as adjuvants

    The Board of Regents of the University of Texas System Β· Granted Jun 22, 2004 Β· Expires Jun 17, 2024

    expired
  5. CA 2506727

    TRAITEMENT DE LA MALADIE DE HUNTINGTON AU MOYEN D'ACIDE EICOSAPENTAENOIQUE

    AMARIN NEUROSCIENCE LTD [GB] Β· Granted Jun 17, 2004 Β· Expires Jun 12, 2024

    expired
  6. US 6750226

    Quinuclidine derivatives and their use as muscarinic M3 receptor ligands

    Almirall Prodesfarma S.A. Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  7. US 6750239

    Pyrazole-derived kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  8. US 6749853

    Combined methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  9. US 6750341

    Preparation of risperidone

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  10. US 6750241

    Protein kinase inhibitors

    Theravance, Inc. Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  11. US 6750350

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  12. US 6750254

    Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  13. US 6750268

    Bonding composition

    KURARAY CO., LTD. Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  14. US 6750234

    Methods for increasing leptin levels using nicotinic acid compounds

    Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  15. US 6750043

    Viral vectors having reduced virulence

    THE ARIZONA BOARD OF REGENTS Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  16. US 6750026

    Screening methods using ligands of the neutropeptide receptor HFGAN72

    The Board of Regents of the University of Texas System Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  17. US 6749864

    Stabilized pharmaceutical composition

    Takeda Chemical Industries Ltd. Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  18. US 6750204

    11-C-substituted ketolides

    Enanta Pharmaceuticals, Inc. Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  19. US 6749856

    Mucosal cytotoxic T lymphocyte responses

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  20. US 6748954

    Drug release from polymer matrices through mechanical stimulation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  21. US 6749847

    Hybrid cytokine of IL-7 and &bgr;-chain of hepatocyte growth factor

    UNIVERSITY OF CONNECTICUT Β· Granted Jun 15, 2004 Β· Expires Jun 10, 2024

    expired
  22. EP 1425277

    HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG

    SMITHKLINE BEECHAM PLC [GB] Β· Granted Jun 9, 2004 Β· Expires Jun 4, 2024

    expired
  23. US 6747129

    Target of RNAIII activating protein(TRAP)

    The Regents of the University of California Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired
  24. US 6747105

    Bis-Schiff base ligand-containing mono-metallocene olefin polymerization catalyst, its preparation process and application

    East China University of Science and Technology Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.